Publications

[35] Nisar Ul Khaliq*, Juyeon Lee, Sangwoo Kim, Daekyung Sung, Hyungjun Kim*. “Pluronic F-68 and F-127 Based Nanomedicines for Advancing Combination Cancer Therapy”, Pharmaceutics, 2023, 15(8), 2102 (IF: 6.525) [Link]

[34] Sohyeon Yu, Sangwoo Kim, Jisu Kim, Ji-Woong Kim, Su Young Kim, Bongjun Yeom, Hyungjun Kim, Won II Choi*, Daekyung Sung*. “Highly Water-Dispersed and Stable Deinoxanthin Nanocapsule for Effective Antioxidant and Anti-Inflammatory Activity”, Int J Nanomedicine, 2023, 2023(18), 4555 (IF: 7.033) [Link]

[33] Jisu Kim, Kum Ju Baek, Sohyun Yu, Hee Sun Yang, Nisar Ul Khaliq, Won Il Choi, Hyungjun Kim*, Daekyung Sung*. “Ferrocene-based acrylate copolymer multilayers with efficient antifouling and electrochemical redox properties”, Electrochim Acta, 2023, 463(20), 142824 (IF: 7.336) [Link]

[32] Nisar Ul Khaliq, Juyeon Lee, Joohyeon Kim, Yejin Kim, Sohyeon Yu, Jisu Kim, Sangwoo Kim, Daekyung Sung*, Hyungjun Kim*. “Mesoporous Silica Nanoparticles as a Gene Delivery Platform for Cancer Therapy”, Pharmaceutics, 2023, 15(5), 1432 (IF: 6.525) [Link]

[31] Sangwoo Kim, Sohyeon Yu, Jisu Kim, Nisar Ul Khaliq, Won Il Choi, Hyungjun Kim*, Daekyung Sung*. “Facile Fabrication of α-Bisabolol Nanoparticles with Improved Antioxidant and Antibacterial Effects”, Antioxidants, 2023, 12(1), 207 (IF: 7.675) [Link]

[30] Hytham H. Gadalla, Seongsoo Lee, Hyungjun Kim, Abigail T. Armstrong, Dina Fathalla, Fawzia Habib Hyunyoung Jeong, Wooin Lee, Yoon Yeo. “Size optimization of carfilzomib nanocrystals for systemic delivery to solid tumor”, J Control Release, 2022, 352, 637-651 (IF: 11.467) [Link]

[29] Juyeon Lee, Hyungjun Kim*. “Tannic acid Mediated Surface Modification of Mesoporous Silica Nanoparticles”, J Adhes Interface, 2022, 23(3), 70-74 (KSCI) [Link]

[28] Jongyoon Shinn†, Juyeon Lee†, Seon Ah Lee, Seon Ju Lee, Ah Hyun Choi, Jung Seo Kim, Su Jin Kim, Hyo Jin Kim, Cherin Lee, Yejin Kim, Joohyeon Kim, Jonghee Choi, Byungchae Jung, Taeho Kim, HyeonTaek Nam, Hyungjun Kim*, Yonghyun Lee*. “Oral Nanomedicines for siRNA Delivery to Treat Inflammatory Bowel Disease”, Pharmaceutics, 2022, 14(9), 1969 (IF: 6.734) [Link]

[27] Si Won Park, Sang Jun Kim, Seong Hyun Park, Juyeon Lee, Hyungjun Kim*, Min Ku Kim*. “Recent Progress in Development and Applications of Ionic Polymer-Metal Composite”, Micromachines, 2022, 13(8), 1290 (IF: 3.523) [Link]

[26] Woohyun Park†, Van Phuc Nguyen†, Yale Jeon†, Bongjoong Kim, Yanxiu Li, Jonghun Yi, Hyungjun Kim, Jung Woo Leem, Young L. Kim, Dong Rip Kim,Yannis M. Paulus, Chi Hwan Lee. “Biodegradable silicon nanoneedles for ocular drug delivery”, Sci Adv, 2022, 8(13), eabn1772 (IF: 14.136) [Link]

[25] Simseok A. Yuk, Hyungjun Kim, Nader S. Abutaleb, Alexandra M. Dieterly, Maie S. Taha, Michael D. Tsifansky, L. Tiffany Lyle, Mohamed N. Seleem, Yoon Yeo. “Nanocapsules modify membrane interaction of polymyxin B to enable safe systemic therapy of Gram-negative sepsis”, Sci Adv, 2021, 7(32), eabj1577 (IF: 14.136) [Link]

[24] Hyungjun Kim, Simseok A. Yuk, Alexandra M. Dieterly, Soonbum Kwon, Jinho Park, Fanfei Meng, Hytham H. Gadalla, Maria Jose Cadena, Tiffany L. Lyle, Yoon Yeo. “Nanosac, a non-cationic and soft polyphenol nanocapsule, enables systemic delivery of siRNA to solid tumors”, ACS Nano, 2021, 15(3), 4576-4593 (IF: 15.881) [Link]

[23] Hyungjun Kim†, Heung Soo Lee†, Yale Jeon, Woohyun Park, Yue Zhang, Bongjoong Kim, Hanmin Jang, Baoxing Xu, Yoon Yeo*, Dong Rip Kim*, and Chi Hwan Lee*. “Bioresorbable, Miniaturized Porous Silicon Needles on a Flexible Water-Soluble Backing for Unobtrusive, Sustained Delivery of Chemotherapy”, ACS Nano, 2020, 14(6), 7227-7236 (IF: 15.881) [Link]

[22] Yearin Jun, Jun Xu, Hyungjun Kim, Ji Eun Park, Yoo-Seong Jeong, Jee Sun Min, Naeun Yoon, Ji Yoon Choi, Jisu Yoo, Soo Kyung Bae, Suk-Jae Chung, Yoon Yeo, Wooin Lee. “Carfilzomib Delivery by Quinic Acid-Conjugated Nanoparticles: Discrepancy Between Tumoral Drug Accumulation and Anticancer Efficacy in a Murine 4T1 Orthotopic Breast Cancer Model”, J Pharm Sci, 2020, 109(4), 1615-1622 (IF: 2.997) [Link]

[21] Hyungjun Kim†, Min Ku Kim†, Hanmin Jang†, Bongjoong Kim, Dong Rip Kim*, and Chi Hwan Lee*. “Sensor-Instrumented Scaffold Integrated with Microporous Spongelike Ultrabuoy for Long-Term 3D Mapping of Cellular Behaviors and Functions”, ACS Nano, 2019, 13(7), 7898-7904 (IF: 15.881) [Link]

[20] Byeongjun Yu, Dobeen Hwang, Hyungsu Jeon, Hyungjun Kim, Yonghyun Lee, Hyeongseop Keum, Jinjoo Kim, Dong Yun Lee, Yujin Kim, Junho Chung, Sangyong Jon. “A hybrid platform based on a bispecific peptide-antibody complex for targeted cancer therapy”, Angew Chem Int Ed Engl, 2019, 58(7), 2005-2010 (IF: 15.336) [Link]

[19] Hyungjun Kim, Dobeen Hwang, Minsuk Choi, Soyoung Lee, Sukmo Kang, Yonghyun Lee, Sunghyun Kim, Junho Chung*, Sangyong Jon*. “Antibody-assisted delivery of a peptide-drug conjugate for targeted cancer therapy”, Mol Pharm, 2019, 16(1), 165-172 (IF: 4.321) [Link]

[18] Hyungjun Kim†, Hanmin Jang†, Bongjoong Kim†, Min Ku Kim, Dae Seung Wie, Heung Soo Lee, Dong Rip Kim*, Chi Hwan Lee*. “Flexible elastomer patch with vertical silicon nanoneedles for intracellular and intratissue nanoinjection of biomolecules”, Sci Adv, 2018, 4(11), eaau6972 (IF: 14.136) [Link]

[17] Soyoung Lee, Yonghyun Lee, Hyungjun Kim, Dong Yun Lee, and Sangyong Jon. “Bilirubin Nanoparticle-Assisted Delivery of a Small Molecule-Drug Conjugate for Targeted Cancer Therapy”, Biomacromolecules, 2018, 19(6), 2270-2277 (IF: 6.092) [Link]

[16] Sukmo Kang, Sukyung Ahn, Jeewon Lee, Jin Yong Kim, Minsuk Choi, Vipul Gujrati, Hyungjun Kim, Jinjoo Kim Eui-Cheol Shin, Sangyong Jon. “Effects of gold nanoparticle-based vaccine size on lymph node delivery and cytotoxic T-lymphocyte responses”, J Control Release, 2017, 28(256), 56-67 (IF: 7.727) [Link]

[15] Jin Yong Kim, Dong Yun Lee, Sukmo Kang, Wenjun Miao, Hyungjun Kim, Yonghyun Lee, Sangyong Jon. “Bilirubin nanoparticle preconditioning protects against hepatic ischemia-reperfusion injury”, Biomaterials, 2017, 133, 1-10 (IF: 10.317) [Link]

[14] Hyungjun Kim, Yonghyun Lee, Sukmo Kang, Minsuk Choi, Soyoung Lee, Sunghyun Kim, Vipul Gujrati, Jinjoo Kim, Sangyong Jon. “Self-assembled nanoparticles comprising aptide-SN38 conjugates for use in targeted cancer therapy”, Nanotechnology, 2016, 27(48), 1-8 (IF: 3.551) [Link] 

[13] Yonghyun Lee, Hyungjun Kim, Sukmo Kang, Jinju Lee, Jinho Park, Sangyong Jon. “Bilirubin Nanoparticles as a Nanomedicine for Anti-Inflammation Therapy”, Angew Chem Int Ed Engl, 2016, 55(26), 7460-7463 (IF: 12.257) [Link]

[12] Wenjun Miao, Hyungjun Kim, Vipul Gujrati, Jin Yong Kim, Hyeongsu Jon, Yonghyun Lee, Minsuk Choi, Jinjoo Kim, Soyoung Lee, Dong Yun Lee, Sukmo Kang, Sangyong Jon. “Photo-decomposable Organic Nanoparticles for Combined Tumor Optical Imaging and Multiple Phototherapies”, Theranostics, 2016, 6(13), 2367-2379 (IF: 8.063) [Link]

[11] Vipul Gujrati, Miriam Lee, Young-Joon Ko, Sangeun Lee, Daejin Kim, Hyungjun Kim, Sukmo Kang, Soyoung Lee, Jinjoo Kim, Hyungsu Jeon, Sun Chang Kim, Youngsoo Jun, and Sangyong Jon. “Bioengineered Yeast-derived Vacuoles with Enhanced Tissue Penetrating Ability for Targeted Cancer Therapy”, PNAS, 2016, 113(3), 710-715 (IF: 9.58) [Link]

[10] Jinju Lee, Phei Er Saw, Vipul Gujrati, Yonghyun Lee, Hyungjun Kim, Sukmo Kang, Minsuk Choi, Jae-Il Kim, and Sangyong Jon. “Mono-arginine Cholesterol-based Small Lipid Nanoparticles as a Systemic siRNA Delivery Platform for Effective Cancer Therapy” Theranostics, 2016, 6(2), 192-203 (IF: 8.063) [Link]

[9] Minsuk Choi, Sang Ho Lee, Won Bae Kim, Vipul Gujrati, Daejin Kim, Jinju Lee, Jae-Il Kim, Hyungjun Kim, Phei Er Saw, Sangyong Jon. “Intracellular Delivery of Bioactive Cargos to Hard-to-Transfect Cells Using Carbon Nanosyringe Arrays Under an Applied Centrifugal g-Force", Adv Healthc Mater, 2016, 5(1), 101-107 (IF: 6.27) [Link]

[8] Phei Er Saw, Jinho Park, Eunbeol Lee, Sukyung Ahn, Jinju Lee, Hyungjun Kim, Jinjoo Kim, Minsuk Choi, Omid C. Farokhzad, and Sangyong Jon. “Effect of PEG Pairing on the Efficiency of Cancer-targeting Liposomes”, Theranostics, 2015, 5(7), 746-754 (IF: 8.063) [Link] 

[7] Hyungjun Kim, Eunhye Lee, In-Hyun Lee, Jinju Lee, Jinjoo Kim, Sunghyun Kim, Yonghyun Lee, Daejin Kim, Minsuk Choi, Yong-Chul Kim, Sangyong Jon. “Preparation and therapeutic evaluation of paclitaxel-conjugated low-molecular-weight chitosan nanoparticles”, Macromol Res, 2014, 22(8), 805-808 (IF: 1.758) [Link]

[6] Hyungjun Kim, Yonghyun Lee, In-Hyun Lee, Sunghyun Kim, Daejin Kim, Phei Er Saw, Jinju Lee, Minsuk Choi, Yong-Chul Kim, Sangyong Jon. “Synthesis and therapeutic evaluation of an aptide-docetaxel conjugate targeting tumor-associated fibronectin”, J Control Release, 2014, 178(28), 118-124 (IF: 7.727) [Link]

[5] Daejin Kim, In-Hyun Lee, Sunghyun Kim, Minsuk Choi, Hyungjun Kim, Sukyung Ahn, Phei Er Saw, Hyungsu Jeon, Yumi Lee, Sangyong Jon. “A specific STAT3-binding peptide exerts antiproliferative effects and antitumor activity by inhibiting STAT3 phosphorylation and signaling”, Cancer Res, 2014, 74(8), 2144-2151 (IF: 8.378) [Link]

[4] Sukyung Ahn, In-Hyun Lee, Eunhye Lee, Hyungjun Kim, Yong-Chul Kim, Sangyong Jon. “Oral delivery of an anti-diabetic peptide drug via conjugation and complexation with low molecular weight chitosan”, J Control Release, 2013, 170(2), 226-232 (IF: 7.727) [Link]

[3] Tae Hyung Kim, Hai Hua Jiang, Yu Seok Youn, Chan Woong Park, Kyung Kook Tak, Seulki Lee, Hyungjun Kim, Sangyong Jon, Xiaoyuan Chen, Kang Choon Lee “Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity” Int J Pharm, 2011, 403(1-2), 285-291 (IF: 4.213) [Link]

[2] Eunhye Lee, Hyungjun Kim, In-Hyun Lee, Sangyong Jon. “In vivo antitumor effects of chitosan-conjugated docetaxel after oral administration”, J Control Release, 2009, 140(2), 79-85 (IF: 7.727) [Link]

[1] Eunhye Lee, Jinju Lee, In-Hyun Lee, Mikyung Yu, Hyungjun Kim, Su Young Chae, Sangyong Jon. “Conjugated chitosan as a novel platform for oral delivery of paclitaxel”, J Med Chem, 2008, 51(20), 6442-6449 (IF: 6.054) [Link]